With these mechanisms in mind, the in vivo effects of a pan-endothelial deficiency in HS sulfation on regional lymph node metastasis (Figure 2) suggested that a lymphatic-exclusive mutation in Ndst1 might also disrupt regional lymph node metastasis using the same tumor model. This evidence concerns the gene NDST1 and neoplasm.